Sage Journals: Discover world-class research

Abstract

The policy debate concerning informed consent for future, unspecified research of stored human biological materials (HBM) would benefit from an understanding of the attitudes of individuals who contribute tissue specimens to HBM repositories. Cancer patients who contributed leftover tissue to the Indiana University Cancer Center Tissue Bank under such conditions were recruited for a mail survey study of their attitudes. Our findings suggest that a clear majority of subjects would permit unlimited future research on stored HBMs without re-contact and re-consent, and a significant minority appear to desire ongoing control over future research uses of their tissue. These differences merit further investigation and suggest that a policy of blanket consent for all future, unspecified research would be premature.

Keywords

data sharing biological materials tissue specimens stored specimens cancer patients' attitudes blanket consent

Get full access to this article

View all access options for this article.

References

Ashburn

T.T.

Wilson

S.K.

Eisenstein

B.I.

(2000). Human Tissue Research in the Genomic Era of Medicine. Archives of Internal Medicine, 160, 3377–3384.

Basic HHS Policy for Protection of Research Subjects, 45 C.F.R. § 46.116(d)(3) (2005).

Caulfield

Brown

, & Meslin

E.M.

(2007). Challenging a Well-Established Consent Norm?: One Time Consent for Biobank Research. Journal of International Biotechnology Law, 4(2), 69–74.

Chen

Rosenstein

D.L.

Muthappan

Palaniappan B.S.

Hilsenbeck

S.G.

Miller

F.G.

Emanuel

E.J.

(2005). Research with stored biological samples: What do research participants want? Archives of Internal Medicine, 165, 652–655.

Eiseman

& Haga

S.B.

(1999). Handbook of human tissue resources: A national resource of human tissue sample. Santa Monica: RAND.

Evans

B.J.

& Meslin

E.M.

(2006). Encouraging translational research through harmonization of FDA and common-rule informed consent requirements for research with banked specimens. Journal of Legal Medicine, 27, 119–166.

Hamajima

Tajima

Oya

Kato

Okuma

Kaneda

(1998). Patients' views on residual blood use for research purposes. Cancer Science, 89(3), 341–345.

Helft

P.R.

& Dougherty

C.A.

(2006). Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. Journal of Clinical Oncology, 24, 4793–4794.

Malone

Catalano

P.J.

O'Dwyer

P.J.

, & Giantonio

(2002). High rate of consent to bank biologic samples for future research: The eastern cooperative oncology group experience. Journal of the National Cancer Institute, 94, 769–771.

10.

Meslin

E.M.

& Quaid

K.A.

(2004). Ethical issues in the storage, collection and research use of human biological materials. Journal of Laboratory and Clinical Medicine, 144, 229–234.

11.

National Bioethics Advisory Commission. (1999). Research involving human biological materials: Ethical issues and policy guidance . Volume 1: Report and recommendations. Rockville: U.S. Government Printing Office.

12.

Partridge

A.H.

& Winer

E.P.

(2002). Informing clinical trial participants about study results. Journal of the American Medical Association, 288, 363–365.

13.

Partridge

A.H.

Burstein

H.J.

Gelman

R.S.

Marcom

P.K.

, & Winer

E.P.

(2003). Do patients participating in clinical trials want to know study results? Journal of the National Cancer Institute, 95(6), 491–492.

14.

United States Department of Health and Human Services, Office for Human Research Protections. Secretary's advisory committee on human research protections, Appendix D. Retrieved February 19, 2007 from http://www.hhs.gov/ohrp/sachrp/appendixd.html.

15.

Wendler

(2006). One-time general consent for research samples. British Medical Journal, 332(7540), 544–547.

Cancer Patients' Attitudes toward Future Research Uses of Stored Human Biological Materials

Abstract

Keywords

Get full access to this article

References